FDA Adverse Event Malfunction Summary report: N

BINAXNOW COVID-19 ANTIGEN SELF-TEST

MDR report key: 13315929 · Received January 21, 2022

Report

Report Number
1221359-2022-00397
Event Type
Malfunction
Date Received
January 21, 2022
Date of Event
December 25, 2021
Report Date
June 2, 2022
Manufacturer
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
Product Code
QKP
UDI-DI
00811877011408
PMA / PMN Number
EUA210264
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
OTHER
Health Professional
N

Narratives

Additional Manufacturer Narrative · 0

THIS INVESTIGATION IS STILL IN PROGRESS. ONCE THE INVESTIGATION IS COMPLETED, A SUPPLEMENTAL REPORT WILL BE PROVIDED. RELATED REPORT: 1221359-2022-00398.

Additional Manufacturer Narrative · 0

TESTING WAS PERFORMED AT ABBOTT DIAGNOSTICS SCARBOROUGH, INC. ON RETAINED KIT LOT 159993 WITH INTERNAL POSITIVE QUALITY CONTROL SAMPLES AND NEGATIVE QUALITY CONTROL SWABS. ALL TEST RESULTS WERE VALID AND PERFORMED AS EXPECTED. ADDITIONALLY, THE MANUFACTURING RECORDS AND QUALITY CONTROL RELEASE TESTING WAS REVIEWED FOR TEST KIT PART NUMBER 195-160/ LOT 159993 , TEST BASE PART NUMBER 195-430H / LOT 150321. THE LOT MET THE REQUIRED RELEASE SPECIFICATIONS. A REVIEW OF THE COMPLAINTS REPORTED AS FALSE POSITIVE PATIENT RESULTS (CONFIRMED AND UNCONFIRMED, CONFLICTING RESULTS) RELATED TO KIT LOT 159993 SHOWED THAT THE COMPLAINT RATE IS (B)(4) (2/314808). ABBOTT DIAGNOSTICS SCARBOROUGH, INC. WAS UNABLE TO DETERMINE THE EXACT ROOT CAUSE OF THE REPORTED ISSUE; HOWEVER, IT COULD POSSIBLY BE RELATED TO ISSUES INCLUDING THE SELF-TEST USER PERFORMANCE, INTERPRETATION OF THE RESULT, OR THE SPECIFIC PATIENT SAMPLE. REFERENCE MFR. REPORTS: 1221359-2022-00397 THROUGH 1221359-2022-00398.

Additional Manufacturer Narrative · 0

THIS INVESTIGATION IS STILL IN PROGRESS. ONCE THE INVESTIGATION IS COMPLETED, A SUPPLEMENTAL REPORT WILL BE PROVIDED. RELATED REPORT: 1221359-2022-00398.

Description of Event or Problem · 0

THE CONSUMER REPORTED A TWO FALSE POSITIVE RESULTS WITH THE BINAXNOW COVID-19 ANTIGEN SELF-TEST USING NASAL SWAB SAMPLES. THE CONSUMER PERFORMED A BINAXNOW ANTIGEN SELF TEST ON THE (B)(6) 2021 AT 10:00AM WHICH GENERATED A POSITIVE RESULT. CONFIRMATION PCR TESTING WAS PERFORMED ON (B)(6) 2021 AT 1:00PM USING AN UNKNOWN SAMPLE TYPE, WHICH GENERATED A NEGATIVE RESULT. THE CONSUMER PERFORMED A SECOND BINAXNOW ANTIGEN SELF TEST ON (B)(6) 2021 AT 1:00PM WHICH GENERATED A POSITIVE RESULT. THE CONSUMER SCHEDULED AN ADDITIONAL CONFIRMATION PCR TEST WITH HIS HEALTHCARE PROVIDER ON (B)(6) 2021. AT THE TIME THAT THIS EVENT WAS REPORTED TO TECHNICAL SERVICES (TS) THE RESULTS WERE NOT AVAILABLE. NO ADVERSE HEALTH EFFECTS WERE REPORTED. THIS MANUFACTURER REPORT ADDRESSES FALSE POSITIVE RESULT 1 OF 2.

Description of Event or Problem · 0

THE CONSUMER REPORTED A TWO FALSE POSITIVE RESULTS WITH THE BINAXNOW COVID-19 ANTIGEN SELF-TEST USING NASAL SWAB SAMPLES. THE CONSUMER PERFORMED A BINAXNOW ANTIGEN SELF TEST ON THE (B)(6) 2021 AT 10:00AM WHICH GENERATED A POSITIVE RESULT. CONFIRMATION PCR TESTING WAS PERFORMED ON (B)(6) 2021 AT 1:00PM USING AN UNKNOWN SAMPLE TYPE, WHICH GENERATED A NEGATIVE RESULT. THE CONSUMER PERFORMED A SECOND BINAXNOW ANTIGEN SELF TEST ON (B)(6) 2021 AT 1:00PM WHICH GENERATED A POSITIVE RESULT. THE CONSUMER SCHEDULED AN ADDITIONAL CONFIRMATION PCR TEST WITH HIS HEALTHCARE PROVIDER ON (B)(6) 2021. AT THE TIME THAT THIS EVENT WAS REPORTED TO TECHNICAL SERVICES (TS) THE RESULTS WERE NOT AVAILABLE. NO ADVERSE HEALTH EFFECTS WERE REPORTED. THIS MANUFACTURER REPORT ADDRESSES FALSE POSITIVE RESULT 1 OF 2.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
729966 BINAXNOW COVID-19 ANTIGEN SELF-TEST LATERAL FLOW IMMUNOASSAY IVD OF COVID-19 QKP ABBOTT DIAGNOSTICS SCARBOROUGH, INC. 159993 00811877011408

Patients

Seq Age Sex Outcome Treatment
1 Male